Total planned funding: $133,121,943
Allocations
Countries/Regions
India | $133,121,943 |
Organizational Types
Unknown | $58,005,673 |
NGO | $37,793,141 |
Own Agency | $20,487,926 |
University | $9,691,895 |
Multi-lateral Agency | $3,116,808 |
Private Contractor | $1,659,000 |
FBO | $1,400,000 |
Other USG Agency | $627,300 |
Host Country Government Agency | $340,200 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $51,935,235 |
Prevention | $33,019,467 |
Care | $15,661,610 |
Management and Operations | $14,625,828 |
Treatment | $7,024,438 |
Testing | $6,427,573 |
Budget Codes
OHSS: Health Systems Strengthening | $27,976,868 |
HVSI: Strategic Information | $18,962,231 |
HVOP: Sexual Prevention: Other Sexual Prevention | $16,299,689 |
HVMS: Management and Operations | $14,625,828 |
HBHC: Care: Adult Care and Support | $9,578,130 |
HTXS: Treatment: Adult Treatment | $6,599,803 |
HVCT: Testing: HIV Testing and Counseling | $6,427,573 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,268,944 |
HLAB: Laboratory Infrastructure | $4,996,136 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,621,759 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,045,396 |
HVTB: Care: TB/HIV | $3,028,897 |
HMBL: Biomedical Prevention: Blood Safety | $2,773,679 |
HKID: Care: Orphans and Vulnerable Children | $2,491,260 |
PDCS: Care: Pediatric Care and Support | $563,323 |
PDTX: Treatment: Pediatric Treatment | $401,158 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$57,381,184
Countries/Regions
FHI 360:
$11,909,571
Countries/Regions
USG Aggregated Agencies:
$8,222,306
Countries/Regions
Voluntary Health Services:
$7,450,000
Countries/Regions